Zhou et al. ever found that the inhibition of AMPK accelerated cell proliferation and promoted malignant behavior such as increased cell migration and anchorage-independent growth, and as a prototypical AMPK activator, AICAR caused the opposite changes in prostate cancer models (21). Here, PRKAA1 is linked to prostate carcinoma.